These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32279217)

  • 1. The Impact of platelet-fibrin clot strength on occurrence and clinical outcomes of peripheral artery disease in patients with significant coronary artery disease.
    Bae JS; Ahn JH; Jang JY; Cho SY; Kang MG; Kim KH; Park HW; Koh JS; Park Y; Hwang SJ; Kwak CH; Hwang JY; Tantry US; Gurbel PA; Jeong YH
    J Thromb Thrombolysis; 2020 Nov; 50(4):969-981. PubMed ID: 32279217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombin-induced platelet-fibrin clot strength: relation to high on-clopidogrel platelet reactivity, genotype, and post-percutaneous coronary intervention outcomes.
    Jeong YH; Bliden KP; Shuldiner AR; Tantry US; Gurbel PA
    Thromb Haemost; 2014 Apr; 111(4):713-24. PubMed ID: 24336898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral artery disease in korean patients undergoing percutaneous coronary intervention: prevalence and association with coronary artery disease severity.
    Kim EK; Song PS; Yang JH; Song YB; Hahn JY; Choi JH; Gwon HC; Lee SH; Hong KP; Park JE; Kim DK; Choi SH
    J Korean Med Sci; 2013 Jan; 28(1):87-92. PubMed ID: 23341717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viscoelastic properties of clot formation and their clinical impact in East Asian versus Caucasian patients with stable coronary artery disease: a COMPARE-RACE analysis.
    Jeong YH; Kevin B; Ahn JH; Chaudhary R; Kang MG; Park HW; Koh JS; Park Y; Tantry US; Gurbel PA
    J Thromb Thrombolysis; 2021 Feb; 51(2):454-465. PubMed ID: 32852671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein and fibrin clot strength measured by thrombelastography after coronary stenting.
    Kreutz RP; Owens J; Breall JA; Lu D; von der Lohe E; Bolad I; Sinha A; Flockhart DA
    Blood Coagul Fibrinolysis; 2013 Apr; 24(3):321-6. PubMed ID: 23429252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and clinical implications of newly revealed, asymptomatic abnormal ankle-brachial index in patients with significant coronary artery disease.
    Lee JY; Lee SW; Lee WS; Han S; Park YK; Kwon CH; Jang JY; Cho YR; Park GM; Ahn JM; Kim WJ; Park DW; Kang SJ; Kim YH; Lee CW; Park SW; Park SJ
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1303-13. PubMed ID: 24355120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of omega-3 fatty acid and C-reactive protein to peripheral artery disease in patients with coronary artery disease.
    Sugiura T; Yoshikawa D; Ishii H; Suzuki S; Kumagai S; Inoue Y; Okumura S; Isobe S; Hayashi M; Ando H; Amano T; Murohara T
    Heart Vessels; 2014 Jul; 29(4):449-55. PubMed ID: 23801460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.
    Berger JS; Abramson BL; Lopes RD; Heizer G; Rockhold FW; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Millegård M; Blomster J; Reist C; Hiatt WR; Patel MR; Mahaffey KW
    Vasc Med; 2018 Dec; 23(6):523-530. PubMed ID: 29992857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations between geriatric nutritional risk index and peripheral artery disease in elderly coronary artery disease patients.
    Kawamiya T; Suzuki S; Ishii H; Hirayama K; Harada K; Shibata Y; Tatami Y; Harata S; Kawashima K; Kunimura A; Takayama Y; Shimbo Y; Osugi N; Yamamoto D; Ota T; Kono C; Murohara T
    Geriatr Gerontol Int; 2017 Jul; 17(7):1057-1062. PubMed ID: 27301335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of concomitant peripheral artery disease on contrast-induced acute kidney injury and mortality in patients with acute coronary syndrome after percutaneous coronary intervention.
    Nakahashi T; Tada H; Sakata K; Yakuta Y; Yoshida T; Tanaka Y; Nomura A; Terai H; Horita Y; Ikeda M; Namura M; Takamura M; Kawashiri MA
    Heart Vessels; 2020 Oct; 35(10):1360-1367. PubMed ID: 32342211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral Artery Disease on The Prognosis Value of Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Retrospective, Single-Center Cohort Study.
    Cheng Z; Qi M; Lang Z; Fang T; Alam M; Yu J; Guo Y
    Heart Surg Forum; 2021 Oct; 24(5):E887-E892. PubMed ID: 34730491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Net platelet clot strength of thromboelastography platelet mapping assay for the identification of high on-treatment platelet reactivity in post-PCI patients.
    Cheng D; Zhao S; Hao Y
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32639536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
    Gupta R; Kirtane AJ; Ozan MO; Witzenbichler B; Rinaldi MJ; Metzger DC; Weisz G; Stuckey TD; Brodie BR; Mehran R; Ben-Yehuda O; Stone GW
    Circ Cardiovasc Interv; 2017 Mar; 10(3):. PubMed ID: 28288963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-fibrin clot strength measured by thromboelastography could predict hypercoagulability and antiplatelet effects in patients after percutaneous coronary intervention.
    Yan XQ; Zhang C; Shi HY; Kong LC; Liu L; Gu ZC; Zhu Q
    Ann Palliat Med; 2021 Mar; 10(3):2448-2457. PubMed ID: 33440968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of obstructive coronary artery disease and major adverse cardiac events in patients with noncoronary atherosclerosis: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) Program.
    Gutierrez JA; Bhatt DL; Banerjee S; Glorioso TJ; Josey KP; Swaminathan RV; Maddox TM; Armstrong EJ; Duvernoy C; Waldo SW; Rao SV
    Am Heart J; 2019 Jul; 213():47-56. PubMed ID: 31102799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of Mean Platelet Volume and Neutrophil to Lymphocyte Ratio Predicts Long-Term Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention.
    Choi DH; Kobayashi Y; Nishi T; Kim HK; Ki YJ; Kim SS; Park KH; Song H; Fearon WF
    Angiology; 2019 Apr; 70(4):345-351. PubMed ID: 29631419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Hypertension, Platelet Reactivity, and the Risk of Adverse Events After Percutaneous Coronary Intervention (From the ADAPT-DES Study).
    Redfors B; Chen S; Ben-Yehuda O; Huang X; Witzenbichler B; Weisz G; Liu Y; Brodie BR; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Mehran R; Stuckey TD; Kirtane AJ; Stone GW
    Am J Cardiol; 2019 Nov; 124(9):1380-1388. PubMed ID: 31477234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH; Arpegård J; Ostergren J; Svensson P
    Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: insights from the Heart and Soul Study.
    Grenon SM; Vittinghoff E; Owens CD; Conte MS; Whooley M; Cohen BE
    Vasc Med; 2013 Aug; 18(4):176-84. PubMed ID: 23835937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered fibrin clot properties in patients with premature peripheral artery disease.
    Okraska-Bylica A; Wilkosz T; Słowik L; Bazanek M; Konieczyńska M; Undas A
    Pol Arch Med Wewn; 2012; 122(12):608-15. PubMed ID: 23235487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.